105 related articles for article (PubMed ID: 26058669)
1. Exploring carbonic anhydrase inhibition with multimeric coumarins displayed on a fullerene scaffold.
Abellán-Flos M; Tanç M; Supuran CT; Vincent SP
Org Biomol Chem; 2015 Jul; 13(27):7445-51. PubMed ID: 26058669
[TBL] [Abstract][Full Text] [Related]
2. Multimeric xanthates as carbonic anhydrase inhibitors.
Abellán-Flos M; Tanç M; Supuran CT; Vincent SP
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):946-52. PubMed ID: 26235915
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale enzyme inhibitors: fullerenes inhibit carbonic anhydrase by occluding the active site entrance.
Innocenti A; Durdagi S; Doostdar N; Strom TA; Barron AR; Supuran CT
Bioorg Med Chem; 2010 Apr; 18(8):2822-8. PubMed ID: 20363143
[TBL] [Abstract][Full Text] [Related]
4. The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors.
Temperini C; Innocenti A; Scozzafava A; Parkkila S; Supuran CT
J Med Chem; 2010 Jan; 53(2):850-4. PubMed ID: 20028100
[TBL] [Abstract][Full Text] [Related]
5. Natural product coumarins that inhibit human carbonic anhydrases.
Davis RA; Vullo D; Maresca A; Supuran CT; Poulsen SA
Bioorg Med Chem; 2013 Mar; 21(6):1539-43. PubMed ID: 22892213
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors drug design.
McKenna R; Supuran CT
Subcell Biochem; 2014; 75():291-323. PubMed ID: 24146385
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors.
Supuran CT
Bioorg Med Chem Lett; 2010 Jun; 20(12):3467-74. PubMed ID: 20529676
[TBL] [Abstract][Full Text] [Related]
8. Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors.
Maresca A; Temperini C; Vu H; Pham NB; Poulsen SA; Scozzafava A; Quinn RJ; Supuran CT
J Am Chem Soc; 2009 Mar; 131(8):3057-62. PubMed ID: 19206230
[TBL] [Abstract][Full Text] [Related]
9. Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups.
Bozdag M; Ferraroni M; Carta F; Vullo D; Lucarini L; Orlandini E; Rossello A; Nuti E; Scozzafava A; Masini E; Supuran CT
J Med Chem; 2014 Nov; 57(21):9152-67. PubMed ID: 25310626
[TBL] [Abstract][Full Text] [Related]
10. Metronidazole-coumarin conjugates and 3-cyano-7-hydroxy-coumarin act as isoform-selective carbonic anhydrase inhibitors.
Bonneau A; Maresca A; Winum JY; Supuran CT
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):397-401. PubMed ID: 22299576
[TBL] [Abstract][Full Text] [Related]
11. New coumarin derivatives as carbonic anhydrase inhibitors.
Karataş MO; Alici B; Cakir U; Cetinkaya E; Demir D; Ergün A; Gençer N; Arslan O
Artif Cells Nanomed Biotechnol; 2014 Jun; 42(3):192-8. PubMed ID: 23656671
[TBL] [Abstract][Full Text] [Related]
12. Binding site comparison for coumarin inhibitors and amine/amino acid activators of human carbonic anhydrases.
Petreni A; Osman SM; Alasmary FA; Almutairi TM; Nocentini A; Supuran CT
Eur J Med Chem; 2021 Dec; 226():113875. PubMed ID: 34634741
[TBL] [Abstract][Full Text] [Related]
13. New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II.
Carta F; Vullo D; Maresca A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2012 Mar; 22(6):2182-5. PubMed ID: 22365761
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.
Durdagi S; Şentürk M; Ekinci D; Balaydın HT; Göksu S; Küfrevioğlu Öİ; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2011 Feb; 19(4):1381-9. PubMed ID: 21282059
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins.
Maresca A; Temperini C; Pochet L; Masereel B; Scozzafava A; Supuran CT
J Med Chem; 2010 Jan; 53(1):335-44. PubMed ID: 19911821
[TBL] [Abstract][Full Text] [Related]
16. Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins.
Balboni G; Congiu C; Onnis V; Maresca A; Scozzafava A; Winum JY; Maietti A; Supuran CT
Bioorg Med Chem Lett; 2012 May; 22(9):3063-6. PubMed ID: 22487176
[TBL] [Abstract][Full Text] [Related]
17. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors.
De Simone G; Alterio V; Supuran CT
Expert Opin Drug Discov; 2013 Jul; 8(7):793-810. PubMed ID: 23627619
[TBL] [Abstract][Full Text] [Related]
18. Designing of novel carbonic anhydrase inhibitors and activators.
Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
[TBL] [Abstract][Full Text] [Related]
19. Biochemical characterization of the δ-carbonic anhydrase from the marine diatom Thalassiosira weissflogii, TweCA.
Del Prete S; Vullo D; De Luca V; Supuran CT; Capasso C
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):906-11. PubMed ID: 24456295
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray crystallographic studies.
Temperini C; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2008 Aug; 18(15):4282-6. PubMed ID: 18640037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
